Swayamjeet Satapathy

177Lu-PSMA-617 versus docetaxel in chemotherapy-naïve metastatic castration-resistant prostate cancer: a randomized, controlled, phase 2 non-inferiority trial

Swayamjeet Satapathy, Bhagwant Rai Mittal, Ashwani Sood et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 53 citations · Full text

Urology, Genitourinary Cancer, Medicine +7

Therapeutic potential of [177Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment

Madhav Prasad Yadav, Sanjana Ballal, Marcel Martin et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2023 · 53 citations

Limited Treatment Options, Therapeutic Potential, Oncology +8

Folic acid and vitamin B12 supplementation in subjects with type 2 diabetes mellitus: A multi-arm randomized controlled clinical trial

Swayamjeet Satapathy, Debapriya Bandyopadhyay, Binod Kumar Patro et al. · Complementary Therapies in Medicine · 2020 · 50 citations

Nutrition, Metabolic Syndrome, Diabetes Management +9

Effect of Tulsi (Ocimum sanctum Linn.) Supplementation on Metabolic Parameters and Liver Enzymes in Young Overweight and Obese Subjects

Swayamjeet Satapathy, Namrata Das, Debapriya Bandyopadhyay et al. · Indian Journal of Clinical Biochemistry · 2016 · 39 citations · Full text

Obesity, Nutrition, Metabolic Syndrome +11

Health-related quality-of-life outcomes with actinium-225-prostate-specific membrane antigen-617 therapy in patients with heavily pretreated metastatic castration-resistant prostate cancer

Ashwani Sood, Swayamjeet Satapathy, BhagwantRai Mittal et al. · Indian Journal of Nuclear Medicine · 2020 · 36 citations · Full text